Provided by Tiger Trade Technology Pte. Ltd.

Disc Medicine

78.65
-1.3800-1.72%
Post-market: 78.650.00000.00%19:30 EDT
Volume:882.04K
Turnover:69.21M
Market Cap:3.02B
PE:-11.99
High:80.53
Open:79.19
Low:77.50
Close:80.03
52wk High:99.50
52wk Low:40.00
Shares:38.39M
Float Shares:32.95M
Volume Ratio:2.03
T/O Rate:2.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.5619
EPS(LYR):-6.0116
ROE:-39.08%
ROA:-23.96%
PB:4.69
PE(LYR):-13.08

Loading ...

Press Release: Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Jul 30

Press Release: Champion IRON Reports ITS Fy2027 FIRST Quarter Results

Dow Jones
·
Jul 30

Disc Medicine CEO John D. Quisel Disposes of Common Shares Worth $2.46 Million

Reuters
·
Jul 15

Disc Medicine COO Jonathan Yen-wen Yu Reports Sale of 100 Common Shares for $8,250

Reuters
·
Jul 10

Did Disc Medicine’s Expanded Hercules Credit Access Just Shift IRON’s Funding Risk Profile?

Simply Wall St.
·
Jul 01

Disc Medicine COO Jonathan Yu Disposes of 300 Common Shares Worth $21,750

Reuters
·
Jul 01

Disc Medicine - Enters First Amendment to Loan Agreement on June 25, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 01

Disc Medicine - to Draw Down $30 Mln of Tranche 1-B Advance - SEC Filing

THOMSON REUTERS
·
Jul 01

Disc Medicine Amends Hercules Loan Agreement, Draws Down $30 Million Tranche

Reuters
·
Jul 01

Disc Medicine COO Jonathan Yen-wen Yu Disposes of 9,700 Common Shares Worth $704,795

Reuters
·
Jun 25

Disc Medicine Stockholders Approve Governance and Executive Pay

TIPRANKS
·
Jun 25

Disc Medicine Shareholders Approve Advisory Executive Pay Vote

Reuters
·
Jun 25

Disc Medicine CEO John Quisel disposes of common shares worth $2.38 million

Reuters
·
Jun 24

Disc Medicine COO Yu Jonathan Yen-Wen sells 18,612 shares for USD 1.29 million

Reuters
·
Jun 19

Disc Medicine (IRON) Stock Could Be 64% Below Fair Value After EHA Trial Update

Simply Wall St.
·
Jun 17

Press Release: LABRADOR IRON ORE ROYALTY CORPORATION - CASH DIVIDEND FOR THE SECOND QUARTER OF 2026 - $0.30 PER COMMON SHARE

Dow Jones
·
Jun 17

Disc Medicine Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jun 16

Wedbush Sticks to Its Buy Rating for Disc Medicine (IRON)

TIPRANKS
·
Jun 16

Disc Medicine price target raised to $85 from $80 at Morgan Stanley

TIPRANKS
·
Jun 16

Disc Medicine posts corporate deck highlighting bitopertin in EPP pipeline progress

Reuters
·
Jun 16